How Digital Healthcare Can Slow MCI and Dementia Progression

As the pharmaceutical industry races to develop treatments for Alzheimer's and other dementias, clinicians are focused on other aspects of disease management, including slowing the progression of cognitive impairment. If caught early, there are noninvasive methods to support patients experiencing the loss of cognitive abilities. Nuvance Health, a seven-hospital system headquartered in Danbury, Connecticut, aims to do just that by expanding its partnership with Neuroglee Health.